Abstract
Background
Lipid-related oxidative stress, such as that caused by malondialdehyde (MDA), acrolein, and 4-hydroxynonenal (4-HNE), is involved in vascular injury in diabetes and hypertension. Olmesartan medoxomil, a blocker of angiotensin II type-I receptor, is an antihypertensive drug with antioxidant properties. In this study, we examined the involvement of oxidative lipids and the effect of olmesartan on lipid peroxidation in the progressive renal injury induced by renal mass reduction in rats.
Methods
Rats were treated with vehicle or olmesartan (0.5 mg/kg or 10 mg/kg) for up to 8 weeks after subtotal nephrectomy. The expression of oxidative lipids and the effect of olmesartan on lipid peroxidation were evaluated by Western blotting and immunostaining of renal tissue.
Results
Immunohistochemical examination revealed that MDA, acrolein, and 4-HNE were scarcely detected in renal cortex in sham-operated rats. On the contrary, these oxidative lipids were observed in injured glomeruli and dilated renal tubules in the ablated kidneys. Western blotting of renal cortical tissue revealed that MDA- or acrolein-bound proteins were mainly detected in the range of 30–90 kDa. Treatment with olmesartan attenuated lipid peroxidation and glomerulosclerosis. The renoprotective and antioxidative effect was higher in rats that received a high dose of olmesartan than in rats in the low-dose group.
Conclusions
These results indicate that oxidative lipids reflect the progression of renal injury induced by subtotal nephrectomy in rats. Olmesartan may have a renoprotective effect, with attenuation of lipid peroxidation.
Similar content being viewed by others
References
S Klahr G Schreiner I Ichikawa (1988) ArticleTitleThe progression of renal disease N Engl J Med 318 1657–66 Occurrence Handle1:STN:280:DyaL1c3jt1ygsg%3D%3D Occurrence Handle10.1056/NEJM198806233182505 Occurrence Handle3287163
ND Vaziri Z Ni F Oveisi K Liang R Pandian (2002) ArticleTitleEnhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency Hypertension 39 135–41 Occurrence Handle1:CAS:528:DC%2BD38Xps1ejug%3D%3D Occurrence Handle10.1161/hy0102.100540 Occurrence Handle11799092
Q Fan J Liao M Kobayashi M Yamashita L Gu T Gohda et al. (2004) ArticleTitleCandesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice Nephrol Dial Transplant 19 3012–20 Occurrence Handle1:CAS:528:DC%2BD2cXhtVCrsrbP Occurrence Handle10.1093/ndt/gfh499 Occurrence Handle15574998
T Miyata S Ishikawa K Asahi R Inagi D Suzuki K Horie et al. (1999) ArticleTitle2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery: role of glycoxidation and lipoxidation reactions in vascular tissue damage FEBS Lett 445 202–26 Occurrence Handle1:CAS:528:DyaK1MXht1OgsL4%3D Occurrence Handle10.1016/S0014-5793(99)00122-2 Occurrence Handle10069401
M Nangaku T Miyata T Sada M Mizuno R Inagi Y Ueda et al. (2003) ArticleTitleAnti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model J Am Soc Nephrol 14 1212–22 Occurrence Handle1:CAS:528:DC%2BD3sXislKjtLY%3D Occurrence Handle10.1097/01.ASN.0000062961.76776.C1 Occurrence Handle12707391
T Konta N Degawa S Kato H Tomoike (1997) ArticleTitleRole of transforming growth factor-beta 1 during glomerulosclerosis in rats with reduced renal mass Clin Exp Nephrol 1 187–94 Occurrence Handle1:CAS:528:DyaK2sXns1yhs7c%3D Occurrence Handle10.1007/BF02480694
K Ikeda Y Nara Y Yamori (1991) ArticleTitleIndirect systolic and mean blood pressure determination by a new tail cuff method in spontaneously hypertensive rats Lab Anim 25 26–9 Occurrence Handle1:STN:280:DyaK3M7os1KhsQ%3D%3D Occurrence Handle10.1258/002367791780808176 Occurrence Handle2010973
DH Kang AH Joly SW Oh C Hugo D Kerjaschki KL Gordon et al. (2001) ArticleTitleImpaired angiogenesis in the remnant kidney model: I. potential role of vascular endothelial growth factor and thrombospondin-1 J Am Soc Nephrol 12 1434–47 Occurrence Handle1:CAS:528:DC%2BD3MXltlSiu7o%3D Occurrence Handle11423572
H Takahashi Y Takeishi T Miyamoto T Shishido T Arimoto T Konta et al. (2004) ArticleTitleProtein kinase C and extracellular signal regulated kinase are involved in cardiac hypertrophy of rats with progressive renal injury Eur J Clin Invest 34 85–93 Occurrence Handle1:CAS:528:DC%2BD2cXitleksrs%3D Occurrence Handle10.1111/j.1365-2362.2004.01304.x Occurrence Handle14764070
T Konta Q Xu A Furusu K Nakayama M Kitamura (2001) ArticleTitleSelective roles of retinoic acid receptor and retinoid x receptor in the suppression of apoptosis by all-trans-retinoic acid J Biol Chem 276 12 697–701 Occurrence Handle10.1074/jbc.M011000200
D Suzuki T Miyata N Saotome K Horie R Inagi Y Yasuda et al. (1999) ArticleTitleImmunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions J Am Soc Nephrol 10 822–32 Occurrence Handle1:CAS:528:DyaK1MXitl2ktbc%3D Occurrence Handle10203367
AB Howard RW Alexander RM Nerem KK Griendling WR Taylor (1997) ArticleTitleCyclic strain induces an oxidative stress in endothelial cells Am J Physiol 272 C421–7 Occurrence Handle1:CAS:528:DyaK2sXhvVCkurk%3D Occurrence Handle10.1152/ajpcell.1997.272.2.C421 Occurrence Handle9124284
K Ranganna Z Yousefipour R Nasif FM Yatsu SG Milton BE Hayes (2002) ArticleTitleAcrolein activates mitogen-activated protein kinase signal transduction pathways in rat vascular smooth muscle cells Mol Cell Biochem 240 83–98 Occurrence Handle1:CAS:528:DC%2BD38XnvVegt74%3D Occurrence Handle10.1023/A:1020659808981 Occurrence Handle12487375
GM Cahuana JR Tejedo J Jimenez R Ramirez F Sobrino FJ Bedoya (2003) ArticleTitleInvolvement of advanced lipooxidation end products (ALEs) and protein oxidation in the apoptotic actions of nitric oxide in insulin secreting RINm5F cells Biochem Pharmacol 66 1963–71 Occurrence Handle1:CAS:528:DC%2BD3sXos1Olsrc%3D Occurrence Handle10.1016/j.bcp.2003.07.004 Occurrence Handle14599554
H Esterbauer RJ Schaur H Zollner (1991) ArticleTitleChemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radic Biol Med 11 81–128 Occurrence Handle1:CAS:528:DyaK3MXmsFSnsbo%3D Occurrence Handle10.1016/0891-5849(91)90192-6 Occurrence Handle1937131
K Uchida M Kanematsu K Sakai T Matsuda N Hattori Y Mizuno et al. (1998) ArticleTitleProtein-bound acrolein: potential markers for oxidative stress Proc Natl Acad Sci USA 95 4882–7 Occurrence Handle1:CAS:528:DyaK1cXivVyqurc%3D Occurrence Handle10.1073/pnas.95.9.4882 Occurrence Handle9560197 Occurrence Handle20182
HL Xu K Yoshida XM Wu M Kohzuki (2001) ArticleTitleEffects of CS-866, an angiotensin II receptor antagonist, in 5/6 nephrectomized spontaneously hypertensive rats (in Japanese) Nippon Jinzo Gakkai Shi 43 580–8 Occurrence Handle1:CAS:528:DC%2BD3MXot1Wjsrg%3D Occurrence Handle11725555
C Van den Branden M Gabriels J Vamecq K Vanden Houte D Verbeelen (1997) ArticleTitleCarvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol Nephron 77 319–24 Occurrence Handle1:CAS:528:DyaK2sXntVajurc%3D Occurrence Handle10.1159/000190295 Occurrence Handle9375827
ND Vaziri F Oveisi Y Ding (1998) ArticleTitleRole of increased oxygen free radical activity in the pathogenesis of uremic hypertension Kidney Int 53 1748–54 Occurrence Handle1:CAS:528:DyaK1cXjs12ls7o%3D Occurrence Handle10.1046/j.1523-1755.1998.00947.x Occurrence Handle9607208
HM Kir MO Dillioglugel M Tugay C Eraldemir HK Ozdogan (2005) ArticleTitleEffects of vitamins E, A and D on MDA, GSH, NO level and SOD activities in 5/6 nephrectomized rats Am J Nephrol 25 441–6 Occurrence Handle1:CAS:528:DC%2BD2MXhtVymu77J Occurrence Handle10.1159/000087825 Occurrence Handle16118481
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Takahashi, T., Konta, T., Takasaki, S. et al. An angiotensin II type-I receptor blocker, olmesartan medoxomil, attenuates lipid peroxidation in renal injury induced by subtotal nephrectomy. Clin Exp Nephrol 11, 202–208 (2007). https://doi.org/10.1007/s10157-007-0481-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-007-0481-8